NMPA Approval

Tirofiban Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20249445

Company河南润弘制药股份有限公司

Registration Date

November 22, 2024

Drug Information

Generic Name

盐酸替罗非班氯化钠注射液

Dosage Form

注射剂

Strength

100ml：盐酸替罗非班（按C₂₂H₃₆N₂O₅S计）5mg与氯化钠0.9g

Drug Type

化学药品

Registration Date

November 22, 2024

Company Information

Applicant Company

Company Name河南润弘制药股份有限公司

Company Address

新郑市庆安路227号

Manufacturing Company

Company Name山东华鲁制药有限公司

Company Address

山东省聊城市茌平区振兴街道华鲁街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸替罗非班氯化钠注射液 - NMPA 批准文号 | MedPath